Skip to content

Drug interactions

Gilteritinib + Indacaterol

Severity: Moderate

Gilteritinib and Indacaterol: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Gilteritinib prolongs the QT interval, and long-acting beta-agonists may add to this effect and lower potassium. The combination may increase the risk of torsades de pointes, particularly in patients with electrolyte abnormalities.

What this interaction means in plain words

Gilteritinib and Indacaterol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Gilteritinib belongs to Oncology; Indacaterol belongs to Respiratory.

Evidence level: Moderate

Why it happens

Additive QT prolongation, with beta-agonist-induced hypokalemia as a possible contributor.

What to do

Obtain a baseline ECG and monitor it periodically, and keep potassium and magnesium in the normal range. Reduce or interrupt the QT-prolonging drug if QTc becomes markedly prolonged.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Gilteritinib and Indacaterol, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Gilteritinib with Indacaterol?

MediHelp rates the interaction as moderate. Gilteritinib and Indacaterol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Gilteritinib prolongs the QT interval, and long-acting beta-agonists may add to this effect and lower potassium. The combination may increase the risk of torsades de pointes, particularly in patients with electrolyte abnormalities.

How serious is the interaction between Gilteritinib and Indacaterol?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain a baseline ECG and monitor it periodically, and keep potassium and magnesium in the normal range. Reduce or interrupt the QT-prolonging drug if QTc becomes markedly prolonged.

What other medicines interact with Indacaterol?

MediHelp also lists interactions of Indacaterol with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Indacaterol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in